Twist Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. 

CEO
Emily Marine Leproust
CEOEmily Marine Leproust
Employees
979
Employees979
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
979
Employees979

TWST Key Statistics

Market cap
2.99B
Market cap2.99B
Price-Earnings ratio
-38.22
Price-Earnings ratio-38.22
Dividend yield
Dividend yield
Average volume
1.49M
Average volume1.49M
High today
$50.02
High today$50.02
Low today
$46.34
Low today$46.34
Open price
$49.15
Open price$49.15
Volume
836.15K
Volume836.15K
52 Week high
$57.88
52 Week high$57.88
52 Week low
$23.30
52 Week low$23.30

Stock Snapshot

Twist Bioscience(TWST) stock is priced at $48.85, giving the company a market capitalization of 2.99B. It carries a P/E multiple of -38.22.

On 2026-02-26, Twist Bioscience(TWST) stock moved within a range of $46.34 to $50.02. With shares now at $48.85, the stock is trading +5.4% above its intraday low and -2.3% below the session's peak.

Trading activity shows a volume of 836.15K, compared to an average daily volume of 1.49M.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $57.88 and a low of $23.30.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $57.88 and a low of $23.30.

TWST News

Simply Wall St 1d
Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal e...

Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal
TipRanks 6d
Twist Bioscience Stock Tumbles after Senior Executive Offloads $2M in Shares

Shares of Twist Bioscience (TWST) declined about 8% on Friday morning after an insider sale raised fresh attention from investors. The drop followed a regulator...

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.